BC ADM Complications Management 4 — Questions and Answers
Question 1: A diabetic patient with gastroparesis has erratic postprandial glucose levels. Which insulin timing strategy is most appropriate?
- Administer rapid-acting insulin after meals once food intake is confirmed (Correct answer)
- Give insulin 30 minutes before meals as standard
- Double basal insulin dose
- Switch to premixed insulin twice daily
Correct answer: Administer rapid-acting insulin after meals once food intake is confirmed
Post-meal rapid-acting insulin administration avoids hypoglycemia from unpredictable gastric emptying causing delayed glucose absorption.
Question 2: Which test is considered the gold standard for diagnosing diabetic gastroparesis?
- Gastric emptying scintigraphy at 4 hours (Correct answer)
- Upper endoscopy
- Barium swallow study
- Wireless motility capsule alone
Correct answer: Gastric emptying scintigraphy at 4 hours
4-hour solid-phase gastric emptying scintigraphy is the gold standard, with retention >10% at 4 hours confirming gastroparesis.
Question 3: A patient with long-standing T1DM reports orthostatic dizziness. Blood pressure drops 28 mmHg systolic upon standing. What is the recommended initial management?
- Increase fluid and salt intake, compression stockings, and head-of-bed elevation (Correct answer)
- Immediate IV fluid bolus
- Start antihypertensive dose reduction only
- Beta-blocker therapy
Correct answer: Increase fluid and salt intake, compression stockings, and head-of-bed elevation
Non-pharmacological measures (fluid/salt loading, compression, head-of-bed elevation) are first-line for diabetic autonomic orthostatic hypotension.
Question 4: Which finding on nerve conduction study confirms diabetic peripheral neuropathy?
- Reduced sural nerve sensory conduction velocity and amplitude (Correct answer)
- Increased motor unit action potential duration
- Normal F-wave latency with abnormal H-reflex
- Increased conduction velocity with decreased amplitude
Correct answer: Reduced sural nerve sensory conduction velocity and amplitude
Reduced sural nerve sensory conduction velocity and amplitude are the earliest and most sensitive NCS findings in diabetic neuropathy.
Question 5: A patient with diabetic nephropathy is on an ACE inhibitor but still has urine ACR of 380 mg/g. Adding which drug class provides additional renoprotection per 2024 ADA guidelines?
- Finerenone (non-steroidal MRA) (Correct answer)
- Spironolactone
- Eplerenone
- Amiloride
Correct answer: Finerenone (non-steroidal MRA)
Finerenone, a non-steroidal mineralocorticoid receptor antagonist, provides additional kidney and cardiovascular protection in CKD with T2DM on top of RAS blockade.
Question 6: Severe non-proliferative diabetic retinopathy follows the '4-2-1 rule.' Which finding triggers the 4-2-1 classification?
- Hemorrhages in 4 quadrants, venous beading in 2 quadrants, or IRMA in 1 quadrant (Correct answer)
- 4 cotton wool spots, 2 hard exudates, 1 new vessel
- Microaneurysms in 4 quadrants only
- 4 disc areas of neovascularization
Correct answer: Hemorrhages in 4 quadrants, venous beading in 2 quadrants, or IRMA in 1 quadrant
The 4-2-1 rule defines severe NPDR: dot/blot hemorrhages in all 4 quadrants, venous beading in ≥2 quadrants, or IRMA in ≥1 quadrant.
Question 7: A diabetic patient with CKD and heart failure is started on dapagliflozin. Which mechanism accounts for its heart failure benefit?
- Osmotic diuresis reducing preload and afterload with direct myocardial effects (Correct answer)
- Increased insulin sensitivity reducing cardiac workload
- ACE inhibitor-like efferent arteriolar dilation
- Reduction in HbA1c lowering cardiac oxidative stress
Correct answer: Osmotic diuresis reducing preload and afterload with direct myocardial effects
SGLT2 inhibitors reduce plasma volume via osmotic diuresis and natriuresis, decrease afterload, and have direct cardioprotective metabolic effects on myocytes.
A diabetic patient with gastroparesis has erratic postprandial glucose levels.
Which insulin timing strategy is most appropriate?